The People of PaxMed

Working with the PaxMed team means you’re working with experts in regulatory affairs, quality assurance, clinical trials, biocompatibility, biomaterials, and implantable devices. Based on your needs, a team will be tailored to ensure that your specific project is successful.

Floyd G. Larson, M.S., M.B.A. – President

Floyd Larson

Floyd oversees all projects and acts as a key liaison between our clients and regulatory agencies. Floyd’s educational background in chemistry, materials science, and business management prepared him for a career in science-based regulatory affairs. Before founding PaxMed, he was Vice President, Scientific Affairs for a major implantable medical device company. Floyd currently serves as Membership Secretary of ASTM International Committee F04 on Medical Devices and is Chairman of ISO/TC 106 Subcommittee 8 on Dental Implants, as well as head of the U.S. delegation to the Subcommittee. He is a member of the American Dental Association’s Standards Committee on Dental Products. He also serves as Convener of the ISO working group responsible for standards for mechanical characterization of dental implants. He is serving as the Industry Representative to the Dental Products Panel of the FDA Medical Devices Advisory Committee, and has authored and coauthored industry-related articles. Floyd was named one of Medical Device & Diagnostic Industry Magazine’s 100 Notable People in the medical device industry.

Kevin A. Thomas, Ph.D. – Vice President and Director of Regulatory Affairs

Kevin Thomas

Kevin is responsible for providing oversight for all regulatory projects, including strategy, personnel, budgets, and timelines. He is actively involved in preparation of regulatory submissions, including 510(k) Premarket Notifications, Investigational Device Exemption (IDE) applications and Technical Files submitted to Notified Bodies for review as a part of the CE Marking process. His experience includes implementation of the design control and design history file requirements of FDA 21 CFR 820. Before joining PaxMed Kevin had seven years of experience with a manufacturer of bioresorbable medical devices, with responsibilities including R&D and product development. Formerly he was Associate Professor, Department of Orthopaedic Surgery, Louisiana State University Medical Center, and adjunct faculty of the Department of Biomedical Engineering, Tulane University. He has authored or co-authored over 85 scientific journal articles and over 200 scientific paper or poster presentations.

Ellen R. Esterline, M.A. – Senior Quality Systems Specialist

Ellen Esterling

Ellen specializes in helping medical device companies face challenging compliance issues in both US and international markets. She trains clients in initiating quality systems, design controls and other quality assurance (QA) needs. Her education and experience include serving as QA for local medical device companies of implantable devices (Class II and III), conducting internal audits, and providing supplier qualification audits. Ellen’s strengths include the ability to apply the regulatory requirements to a client’s current need and an ongoing involvement with medical device regulations such as US FDA Quality System Regulation (21 CFR 820), ISO 13485:2012 for Medical Devices Quality Management Systems, Europe’s Medical Device Directive (MDD) including Notified Bodies and obtaining the CE Mark, Health Canada Medical Device Regulations and the California Food and Drug Branch.

Christine L. Peterson, B.A. – Director of Clinical Studies

Christine Peterson

Christine directs our Clinical Studies Department with overall responsibility for study management, the monitoring staff, and ensuring appropriate reporting of the study. With her training in clinical trial management and her more than 14 years of Investigational Device Exemption (IDE) and post-market clinical trial experience, she provides the in-house study leadership. This includes the initial writing of the protocol and study materials, working with the staff and the client to clarify the study goals and to meet FDA’s requirements. Christine also leads clinical study training, including the design and conduct for initial and on-going training of study center personnel and monitors, and coordinates the FDA relationships and reporting requirements.

Lauren M. Wessell, B.S., RAC – Regulatory Specialist

Lauren is actively involved in regulatory strategy and the preparation of regulatory submissions, especially 510(k) Premarket Notifications. She has experience with global medical device and in vitro diagnostic manufacturers, working on submissions for US FDA, Health Canada, and European Union Notified Bodies.  Her career evolution to regulatory affairs from research and development and operations provides diverse knowledge in regulatory compliance, product development, and product lifecycles. She is particularly versed in labeling strategies, implementation of unique device identification programs, design controls, and packaging engineering.

Vincent W. Li, PHARM.D. – Regulatory Specialist

As a contributor to PaxMed’s Regulatory Affairs services to our clients, Vincent works with the PaxMed team and our clients to prepare 510(k) Premarket Notifications. Before coming to PaxMed, he successfully completed and closed out a yearlong medical device regulatory project focusing on registration and compliance activities in China for Johnson & Johnson Vision. Within the medical device space, he has experience with cataract products as well as understanding of China National Medical Products Administration (NMPA, formerly known as the CFDA) requirements for medical devices. He is a pharmacist by training and maintains an active pharmacist license with the California State Board of Pharmacy.

Claudia H. Fell, B.S. – Office Manager

Claudia Fell

Claudia is in charge of office administration, assists with document archiving and spearheads production of all regulatory submissions. She provides oversight of the myriad day-to-day tasks, and works with accounting, data management, and the regulatory departments. She also organizes staff meetings, effectively contributing to the efficiency of our team. Her experience in medical offices and hospitals, combined with her degree in mathematics and medical technology have equipped Claudia for her role in coordinating our regulatory affairs office.

Jim Duvall, B.A., M.M., M.C.M – Manager of Business Administration & Development

Jim Duvall

As the initial responder to our prospective clients, Jim manages PaxMed’s business development and works with PaxMed consultants to initiate new projects from companies around the globe. Our clients are seeking to market their medical devices in the United States and in Europe and he monitors progress on submissions to ensure that optimal business flows are achieved. An integral part of his responsibilities includes managing financial matters with our clients.  Jim comes to us with several years of accounting, project management, and enterprise management experience, both in corporate and small business entities.